China Non-Invasive Prenatal Testing Market Size, Trends, Share, Growth, Opportunity, and Forecast 2022 – 2028
China Non–Invasive Prenatal Testing (NIPT) market size is anticipated to reach USD 825 million by 2028, registering a CAGR of 6.4% over the forecast period.
This new market report presents a comprehensive study of the entire China non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the China non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in China.
The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, NIPT test volume, revenues and provides forecasts through 2028. The report also includes an assessment of comparative test analysis by companies. It also covers reimbursement patterns and offers a clear view of the regulatory landscape in the China non–invasive prenatal testing market. Key trends in terms of collaboration deals, partnerships, mergers & acquisitions, venture capital investment, distribution, and licensing agreements are analyzed in detail. The report also explores the detailed description of market drivers and inhibitors of the China non–invasive prenatal testing market.
The report concludes with the profiles of major players in the China non–invasive prenatal testing market. The key market players are evaluated on various parameters such as business overview, product outlook, and key development in the non–invasive prenatal testing market in China.
This Comprehensive China Non-Invasive Prenatal Testing Market Research Report Provides:
To Analyse the Historical Growth in the Market Size of the China Non–Invasive Prenatal Testing Market from 2018 to 2021
To Estimate and Forecast the Market Size of the China Non–Invasive Prenatal Testing Market from 2022 to 2028 and Growth Rate until 2028
Evaluates the Number of NIPT Tests Performed in China with Six Years Forecast
Assessment of Market Potential and Opportunities for this Innovation-Driven China Non–Invasive Prenatal Testing Market with Six Years Forecast
Meticulously Assesses the Overall China Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
Detailed Insights into the Regulatory Framework of the China Non–Invasive Prenatal Testing Market
Features Reimbursement Patterns of the China Non–Invasive Prenatal Testing Market
Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development
The Leading Companies for the China Non–Invasive Prenatal Testing Market are Listed Below:
Basetra
Berry Genomics
BGI Diagnosis Co. Ltd
Key Questions Answered in this Report:
What is the current scenario of the China non–invasive prenatal testing market?
What is the total market size and forecast (until 2028) for the China non–invasive prenatal testing market?
How has the potential China market performed so far and how will it perform in the coming years?
How many NIPT tests performed in China during 2018 – 2028?
What are the key marketed NIPT tests available in China?
What are the major drivers of the China non–invasive prenatal testing market?
What are the major inhibitors of the China non–invasive prenatal testing market?
What is the reimbursement pattern in the China non–invasive prenatal testing market?
What is the regulatory framework in the China non–invasive prenatal testing market?
What are the major deals and agreement happenings in the non–invasive prenatal testing market?
Who are the top Chinese market players? What are their happenings, current developments, and scenarios?
How is the Chinese market predicted to develop in the future?
- 1. Executive Summary
- 2. China Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028)
- 3. China Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028)
- 4. China Actual Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028)
- 5. China Potential Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028)
- 6. China Non–Invasive Prenatal Testing Market Growth Drivers and Challenges
- 6.1 Market Growth Drivers
- 6.2 Market Challenges
- 7. Non–Invasive Prenatal Testing Comparative Analysis
- 8. Reimbursement Environment of the China Non-Invasive Prenatal Testing Market
- 9. Regulation Framework of the China Non-Invasive Prenatal Testing Market
- 10. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
- 10.1 Collaboration Deals
- 10.2 Venture Capital Investment
- 10.3 Mergers and Acquisitions
- 10.4 Exclusive Agreement
- 10.5 Licensing Agreement
- 10.6 Distribution Agreement
- 10.7 Partnership Deals
- 11. Key Companies Analysis
- 11.1 BGI Diagnosis Co. Ltd
- .1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Recent Development
- 11.2 Berry Genomics
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Recent Development
- 11.3 Basetra Medical Technology Co. Ltd.
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.2.1 Business Overview
- List of Tables
- Table 6–1: Maternal Age at Delivery and Risk of Down Syndrome
- Table 7–1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
- Table 10–1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
- Table 10–2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
- Table 10–3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
- Table 10–4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
- Table 10–5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
- Table 10–6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
- Table 10–7: Partnership Deals in the Non–Invasive Prenatal Testing Market
- List of Figures
- Figure 2–1: China Actual NIPT Test Volume (Number),2018 – 2021
- Figure 2–2: China Actual NIPT Test Volume Forecast (Number),2022 – 2028
- Figure 3–1: China Potential NIPT Test Volume (Number),2018 – 2021
- Figure 3–2: China Potential NIPT Test Volume Forecast (Number),2022 – 2028
- Figure 4–1: China Actual NIPT Test Market Size (Million US$),2018 – 2021
- Figure 4–2: China Actual NIPT Test Market Size Forecast (Million US$),2022 – 2028
- Figure 5–1: China Potential NIPT Test Market Size (Million US$),2018 – 2021
- Figure 5–2: China Potential NIPT Test Market Size Forecast (Million US$),2022 – 2028
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook